Skip to main content
. 2023 Sep 19;24(18):14256. doi: 10.3390/ijms241814256

Figure 1.

Figure 1

A schematic overview of the main challenges for glioblastoma (GBM) clinical care mentioned in this review. The challenges include the infiltrative nature of GBM tumors, substantial heterogeneity between patients or cells inside the tumor, drug delivery through the BBB, and therapeutic limitations.